Abstract
Gallbladder stones are a common clinical finding in the Western population: a prevalence rate of 10–15% in adult European and of 3–5% in African and Asian populations has been reported. In several Western countries 80% of gallstones are cholesterol stones in a matrix of bile pigments calcium salts and glycoproteins [1–5]. Adut age, female gender, fecundity and family history of gallstone disease are strongly associated with the formation of cholesterol stones. Moreover, specific dietetic regimens, such as high cholesterol and high carbohydrate diets, are associated with an increased risk of gallstone formation [6]. Obesity (body mass index BMI>30 kg/m2), and other factors contributing to the metabolic syndrome, such as dyslipidemia, hyperinsulinemia, insulin resistance or type 2 diabetes, are also well established risk factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marschall HU, Einarsson C (2007) Gallstone disease. J Intern Med 261:529–542
Kratzer W, Mason RA, Kachele V (1999) Prevalence of gallstones in sonographic surveys world-wide. J Clin Ultrasound 27:1–7
Everhart JE, Khare M, Hill M et al (1999) Prevalence and ethnic difference in gallbladder disease in the United States. Gastroenterology 117:632–639
Sampliner RE, Bennett PH, Comess LJ et al (1970) Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 283:1358–1364
Everhart JE, Yeh F, Lee ET et al (2002) Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 35:1507–1512
EA Shaffer (2006) Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20:981–996
Wang SN, Yeh YT, Yu ML et al (2006) Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest 36:176–180
Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347–355
Friedman GD, Kamel WB, Dawber TR (1996) The epidemiology of gallbladder disease: observations in the Framingham study. J Chronic Dis 19:273–292
Amaral JF, Thompson WR (1985) Gallbladder disease in the morbidly of obese. Am J Surg 149:551–557
Aidonopoulos AP, Papavramidis ST, Zaraboukas TG et al (1994) Gallbladder findings after cholecystectomy in morbidly obese patients. Obes Surg 4:8–12
Calhoun RC, Willbanks O (1987) Coexistence of gallbladder disease and morbid obesity. Am J Surg 154:665–658
Fobi M, Lee H, Igwe D et al (2002) Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12:350–353
Hamad GG, Ikramuddin S, Gourash WF et al (2003) Elective cholecystetomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg 13:76–81
Zhang Y, Proenca R, Maffei M et al (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432
Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763–770
VanPatten S, Ranginani N, Shefer S et al (2001) Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 281:393–404
Hyogo H, Roy S, Paigen B et al (2002) Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 277:117–124
Tran KQ, Sartz-Basile DA, Nakeeb A et al (2003) Gallbladder motility in agouti-yellow and leptin-resistant obese mice. J Surg Res 113:56–61
Graewin SJ, Kiely JM, Lee KH et al (2004) Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time. J Gastrointest Surg 8:824–829
Graewin SJ, Lee KH, Kiely JM et al (2004) Gallbladder myocytes are short and cholecystokinin-resistant in o bese diabetic mice. Surgery 136:431–436
Tsai CJ, Leitzmann MF, Willett WC et al (2005) Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology 129:105–112
Sasazuki S, Kono S, Todoroki I et al (1999) Impaired glucose tolerance, diabetes mellitus, and gallstone disease: and extended study of male self-defense officials in Japan. Eur J Epidemio 15:245–251
Papavramidis S, Deligianidis N, Papavramidis T et al (2003) Laparoscopic cholecystectomy after bariatric surgery. Surg Endosc 17:1061–1064
Jiffry BO, Shaffer EA, Saccone GTP et al (2003) Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obesity. Can J Gastroenterol 17:169–174
Erlinger S (2000) Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol 12:1347–1352
Shiffman ML, Kaplan GD, Brinkman-Kaplan V et al (1995) Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Int Med 122:899–905
Shiffman ML, Sugerman HJ, Kellum JM et al (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000–1005
Shiffman ML, Sugerman HJ, Kellum JM et al (1993) Gallstones in patients with morbid obesity: relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes 17:153–158
Worobetz LJ, Inglis FG, Shaffer EA (1993) The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol 88:1705–1710
Kiewiet RM, Durian MF, van Leersum M et al (2006) Gallstone formation after weight loss following gastric banding in morbidly obese Dutch patients. Obes Surg 16(5):592–596
Miller K, Hell E, Lang B et al (2003) Gallstone formation prophylaxis after gastric restrictive procedures for weight loss. Ann Surg 238:697–702
Shiffman ML, Sugerman HJ, Kellum JM et al (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000–1005
Scopinaro N, Gianetta E, Civalleri D (1979) Biliopancreatic bypass for obesity II Initial experience in man. Br J Surg 66:618–620
Scopinaro N, Gianetta E, Civalleri D et al (1980) Two years experience with bilio-pancreatic bypass. Am J Clin Nutr 33:506–514
Bardaro SJ, Gagnér M, Consten E et al (2004) Is routine cholecystectomy during bilio pancreatic diversion with duodenal switch really necessary? Abstract ASBS, San Diego
Hess DS, Hess DW (1998) Biliopancreatic diversion with a duodenal switch. Obes Surg 8:267–282
Friedman GD (1993) Natural history of asymptomatic and symptomatic gallstones. Am J Surg 165:399–404
Attili AF, De Santis A, Capri R et al (1995) The natural history of gallstones: the GREPCO experience. Hepatology 21:655–660
Alponat A, Kun CK, Koh BC (1997) Predictive factors for conversion of laparoscopic cholecystectomy. World J Surg 21:629–633
Sidhu RS, Raj PK, Treat RC (2007) Obesity as a factor in laparoscopic holecystectomy. Surg Endosc 21:774–776
Simopoulos C, Polychronidis A, Botaitis S (2005) Laparoscopic cholecystectomy in obese patients. Obes Surg 15:243–246
Westling A, Bergqvist D et al (2002) Incidence of deep venous thrombosis in patients undergoing obesity surgery. World J Surg 26:470–473
Fakhry SM, Herbst CA, Buckwalter JA (1987) Cholecystectomy in morbidly obese patients. Am Surg 53:26–28
Jones KB Jr (1995) Simultaneous cholecystectomy: to be or not to be. Obes Surg 5:52–54
Mason E, Renquist KE (2002) Gallbladder management in obesity surgery Obes surg 12:222–229
Scott DJ, Villegas L, Sims TL et al (2003) Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. Surg Endosc 17:1796–802
Angrisani L, Lorenzo M, De Palma G et al (1995) Laparoscopic cholecystectomy in obese patients compared with nonobese patients. Surgical Laparose Endosc 5:197–201
Sugerman HJ, Brewer WH, Shiffman ML et al (1995) A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric bypass-induced rapid weight loss. Am J Surg 169:91–97
Martinez J, Guerrero L, Byers P et al (2006) Endoscopic retrograde cholangiopancreatography and gastroduodenoscopy after Roux-en-Y gastric bypass. Surg Endosc 20(10):1548–1550
Goitein D, Gagn DJ, Papasavas PK et al (2006) Percutaneous computed tomography-guided gastric remnant access after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2(6):651–655
Fobi M, Lee H, Igwe D (2002) Prophylactric cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12(3):350–353
Ross AS, Semrad C, Alverdy J et al (2006) Use of double-balloon enteroscopy to perform PEG in the excluded stomach after Roux-en-Y gastric bypass. Gastrointest Endosc 64(5):797–800
Ceppa FA, Gagne DJ, Papasavas PK et al (2007) Laparoscopic transgastric endoscopy after Rouxen-Y gastric bypass Surg Obes Relat Dis 3(1):21–24
Mutignani M, Marchese M, Tringali A et al (2007) Laparoscopy-assisted ERCP after biliopancreatic diversion. O bes Surg 17(2):251–254
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Italia
About this chapter
Cite this chapter
Rizzello, M., Casella, G., Abbatini, F., Silecchia, G., Basso, N. (2008). Biliary Lithiasis and Obesity. In: Biliary Lithiasis. Springer, Milano. https://doi.org/10.1007/978-88-470-0763-5_33
Download citation
DOI: https://doi.org/10.1007/978-88-470-0763-5_33
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0762-8
Online ISBN: 978-88-470-0763-5
eBook Packages: MedicineMedicine (R0)